» Articles » PMID: 30428619

Reversal of Multidrug Resistance in Human Colon Cancer and Human Leukemia Cells by Three Plant Extracts and Their Major Secondary Metabolites

Overview
Specialty Pharmacology
Date 2018 Nov 16
PMID 30428619
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

We studied the effect of three plant extracts (, , ) and six of their major secondary metabolites (glycyrrhizic acid, 18β glycyrrhetinic acid, liquiritigenin, isoliquiritigenin, paeoniflorin, ursolic acid) on the multidrug resistant human colon cancer cell line Caco-2 and human leukemia cell line CEM/ADR 5000 as compared to the corresponding sensitive cell line CCRF-CEM, and human colon cancer cells HCT-116, which do not over-express ATP-binding cassette (ABC) transporters. The cytotoxicity of single substances in sensitive and resistant cells was investigated by MTT assay. We also applied combinations of extracts or single compounds with the chemotherapeutic agent doxorubicin or doxorubicin plus the saponin digitonin. The intracellular retention of the ABC transporter substrates rhodamine 123 and calcein was examined by flow cytometry to explore the effect of the substances on the activity of ABC transporters P-glycoprotein and MRP1. Real-time PCR was applied to analyse the gene expression changes of ABCB1, ABCC1, caspase 3, caspase 8, AhR, CYP1A1, and GSTP1 in resistant cells under the treatment of the substances. All the substances moderately inhibited cell growth in sensitive and resistant cells to some degree. Whereas ursolic acid showed IC of 14 and 22 µM in CEM/ADR 5000 and Caco-2 cells, respectively, glycyrrhizic acid and paeoniflorin were inactive with IC values above 400 μM. Except for liquiritigenin and isoliquiritigenin, all the other substances reversed MDR in CEM/ADR 5000 and Caco-2 cells to doxorubicin. Ue, ga, 18ga, and urs were powerful reversal agents. In CEM/ADR 5000 cells, high concentrations of all the substances, except extract, increased calcein or rhodamine 123 retention in a dose-dependent manner. In Caco-2 cells, all the substances, except liquiritigenin, retained rhodamine 123 in a dose-dependent manner. We also examined the effect of the plant secondary metabolite (PSM) panel on the expression of ABCB1, ABCC1, caspase 3, caspase 8, AhR, CYP1A1, and GSTP1 genes in MDR cells. The extracts and individual PSM could reverse MDR in CEM/ADR 5000 and Caco-2 cells, which overexpress ABC transporters, in two- and three-drug combinations. Most of the PSM also inhibited the activity of ABC transporters to some degree, albeit at high concentrations. Ue, ga, 18ga, and urs were identified as potential multidrug resistance (MDR) modulator candidates, which need to be characterized and validated in further studies.

Citing Articles

Advances in the roles of glycyrrhizic acid in cancer therapy.

Zhang Y, Sheng Z, Xiao J, Li Y, Huang J, Jia J Front Pharmacol. 2023; 14:1265172.

PMID: 37649893 PMC: 10463042. DOI: 10.3389/fphar.2023.1265172.


Exploring the Mechanisms of Self-made Kuiyu Pingchang Recipe for the Treatment of Ulcerative Colitis and Irritable Bowel Syndrome using a Network Pharmacology-based Approach and Molecular Docking.

Wen Y, Wang X, Si K, Xu L, Huang S, Zhan Y Curr Comput Aided Drug Des. 2023; 20(5):534-550.

PMID: 37190808 DOI: 10.2174/1573409919666230515103224.


Natural Products as a Tool to Modulate the Activity and Expression of Multidrug Resistance Proteins of Intestinal Barrier.

Martins-Gomes C, Silva A J Xenobiot. 2023; 13(2):172-192.

PMID: 37092502 PMC: 10123636. DOI: 10.3390/jox13020014.


Modulation of Cellular Senescence in HEK293 and HepG2 Cells by Ultrafiltrates UPla and ULu Is Partly Mediated by Modulation of Mitochondrial Homeostasis under Oxidative Stress.

Zhou J, Liu K, Bauer C, Bendner G, Dietrich H, Slivka J Int J Mol Sci. 2023; 24(7).

PMID: 37047720 PMC: 10095350. DOI: 10.3390/ijms24076748.


Recent Advances in (Licorice)-Containing Herbs Alleviating Radiotherapy- and Chemotherapy-Induced Adverse Reactions in Cancer Treatment.

Wang K, Yu Y, Chen H, Chiang Y, Ali M, Shieh T Metabolites. 2022; 12(6).

PMID: 35736467 PMC: 9227067. DOI: 10.3390/metabo12060535.


References
1.
Su X, Wu L, Hu M, Dong W, Xu M, Zhang P . Glycyrrhizic acid: A promising carrier material for anticancer therapy. Biomed Pharmacother. 2017; 95:670-678. DOI: 10.1016/j.biopha.2017.08.123. View

2.
Li X, Hu J, Wang B, Sheng L, Liu Z, Yang S . Inhibitory effects of herbal constituents on P-glycoprotein in vitro and in vivo: herb-drug interactions mediated via P-gp. Toxicol Appl Pharmacol. 2014; 275(2):163-75. DOI: 10.1016/j.taap.2013.12.015. View

3.
Glavinas H, von Richter O, Vojnits K, Mehn D, Wilhelm I, Nagy T . Calcein assay: a high-throughput method to assess P-gp inhibition. Xenobiotica. 2011; 41(8):712-9. DOI: 10.3109/00498254.2011.587033. View

4.
Wink M . Evolutionary advantage and molecular modes of action of multi-component mixtures used in phytomedicine. Curr Drug Metab. 2008; 9(10):996-1009. DOI: 10.2174/138920008786927794. View

5.
Ludescher C, Thaler J, Drach D, Drach J, Spitaler M, Gattringer C . Detection of activity of P-glycoprotein in human tumour samples using rhodamine 123. Br J Haematol. 1992; 82(1):161-8. DOI: 10.1111/j.1365-2141.1992.tb04608.x. View